Back
About the Global Fund
-
COVID-19 Urgent Mitigation Plan
- Our plan to mitigate the impact of COVID-19 on countries affected by HIV, TB and malaria
People & Structures
Funding Model
Investments & Results
-
Explore contributions, investments and results in our fight against AIDS, tuberculosis and malaria around the world.
- Data Explorer
- Funding Decisions
- Data Service
HIV & AIDS
Tuberculosis
MalariaNews
Updates
Stories
-
10 July 2020
Disruptions in HIV, TB and Malaria Programs due to COVID-19 -
10 July 2020
AIDS 2020: Fighting HIV in the Shadow of COVID-19 -
09 July 2020
Fighting HIV in India during COVID-19 -
07 July 2020
AIDS 2020: Going Forward in Partnership -
06 July 2020
Lifeline During Lockdown: Delivering Medicines During COVID-19 -
06 July 2020
We Cannot Go Backwards
Featured Publication
Documents by type
GF/B38/EDP18
Approved by the Board on: 26 April 2018
Key Performance Indicator 12b: Availability of affordable health technologies: Affordability
1. Based on the recommendation of the Audit and Finance Committee, the Board approves the 2018 performance target for Key Performance Indicator 12b as presented in GF/B38/ER13A.
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.